Registration Frequencies

  • Weekly updated frequencies of observation starts at registration by medication are shown.
     
    Fig 1) Patient numbers by biologic treatment at inclusion
    Last update: | n=
    Fig 1) Patient numbers by biologic treatment at inclusion

     

    Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
    Last update: | n=
    Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

     

    Show table for Fig. 1/2Hide table

    Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
    Adalimumab 1019 363
    Brodalumab 365 0
    Certolizumab 101 0
    Efalizumab 35 0
    Etanercept 309 59
    Golimumab 25 0
    Guselkumab 608/td>

    0
    Infliximab 101 1
    Ixekizumab 493 0
    Risankizumab 292 0
    Secukinumab 1301 0
    Tildrakizumab 354 0
    Ustekinumab 711 0
    Apremilast 531 0
    Ciclosporin 392 0
    Fumaderm 2606 0
    Skilarence 1807 0
    Methotrexate 3269 0
    Tofacitinib 1 0
    other systemics 328 0

     

    Fig. 3) Rate of patients by medication class at inclusion
    Last update: | n=
    Fig. 3) Rate of patients by medication class at inclusion

     

    Fig. 4) Rate of patients by type of registry site
    Last update: | n=
    Fig. 4) Rate of patients by type of registry site

     

    Fig. 5) Registered PsoBest centers
    Last update: | n= | updated monthly
    Fig. 5) Registered PsoBest centers